Esler W P, Wolfe M S
Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Science. 2001 Aug 24;293(5534):1449-54. doi: 10.1126/science.1064638.
The amyloid beta-peptide (Abeta) is a principal component of the cerebral plaques found in the brains of patients with Alzeheimer's disease (AD). This insoluble 40- to 42-amino acid peptide is formed by the cleavage of the Abeta precursor protein (APP). The three proteases that cleave APP, alpha-, beta-, and gamma-secretases, have been implicated in the etiology of AD. beta-Secretase is a membrane-anchored protein with clear homology to soluble aspartyl proteases, and alpha-secretase displays characteristics of certain membrane-tethered metalloproteases. gamma-Secretase is apparently an oligomeric complex that includes the presenilins, which may be the catalytic component of this protease. Identification of the alpha-, beta-, and gamma-secretases provides potential targets for designing new drugs to treat AD.
淀粉样β肽(Aβ)是阿尔茨海默病(AD)患者大脑中发现的脑斑的主要成分。这种不溶性的40至42个氨基酸的肽是由Aβ前体蛋白(APP)裂解形成的。裂解APP的三种蛋白酶,α-、β-和γ-分泌酶,与AD的病因有关。β-分泌酶是一种膜锚定蛋白,与可溶性天冬氨酸蛋白酶有明显的同源性,α-分泌酶具有某些膜结合金属蛋白酶的特征。γ-分泌酶显然是一种寡聚复合物,包括早老素,早老素可能是这种蛋白酶的催化成分。鉴定α-、β-和γ-分泌酶为设计治疗AD的新药提供了潜在靶点。